Anandamide

Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.

Cross Reference

Introduction

To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Anandamide?

Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Anandamide

MeSH term MeSH ID Detail
Stomach Ulcer D013276 75 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Pain D010146 64 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Fatty Liver D005234 48 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Melanoma D008545 69 associated lipids
Per page 10 20 50 100 | Total 105

PubChem Associated disorders and diseases

What pathways are associated with Anandamide

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Anandamide?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Anandamide?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Anandamide?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Anandamide?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Anandamide?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Anandamide

Download all related citations
Per page 10 20 50 100 | Total 2222
Authors Title Published Journal PubMed Link
Price TJ et al. A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons. 2005 Neuropharmacology pmid:15992578
Bouaboula M et al. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. 2005 Eur. J. Pharmacol. pmid:15987634
Glaser ST et al. Anandamide transport: a critical review. 2005 Life Sci. pmid:15979096
Hohmann AG et al. An endocannabinoid mechanism for stress-induced analgesia. 2005 Nature pmid:15973410
Tian X et al. The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer. 2005 J. Biol. Chem. pmid:15964843
Ambrosi S et al. On the importance of anandamide structural features for its interactions with DPPC bilayers: effects on PLA2 activity. 2005 J. Lipid Res. pmid:15961786
Karava V et al. Anandamide metabolism by Tetrahymena pyriformis in vitro. Characterization and identification of a 66 kDa fatty acid amidohydrolase. 2005 Biochimie pmid:15951097
Gamber KM et al. Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. 2005 Neuropharmacology pmid:15949823
Ueda N et al. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines. 2005 Life Sci. pmid:15949819
Justinova Z et al. The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys. 2005 J. Neurosci. pmid:15944392
Balas L et al. Synthesis of a photoactivatable probe of the anandamide re-uptake. 2005 Nat. Prod. Res. pmid:15938150
Abalo R et al. Evaluation of the effect of age on cannabinoid receptor functionality and expression in guinea-pig ileum longitudinal muscle-myenteric plexus preparations. 2005 Jul 22-29 Neurosci. Lett. pmid:15936532
De Petrocellis L and Di Marzo V Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels. 2005 Life Sci. pmid:15936040
Fowler CJ et al. The endocannabinoid signaling system: pharmacological and therapeutic aspects. 2005 Pharmacol. Biochem. Behav. pmid:15935456
Bojesen IN and Hansen HS Membrane transport of anandamide through resealed human red blood cell membranes. 2005 J. Lipid Res. pmid:15930521
Kwolek G et al. [Influence of anandamide, the endogenous agonist of cannabinoid receptors on the circulatory system]. 2005 Postepy Hig Med Dosw (Online) pmid:15928605
Myrdal SE and Steyger PS TRPV1 regulators mediate gentamicin penetration of cultured kidney cells. 2005 Hear. Res. pmid:15925202
Bari M et al. Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells. 2005 J. Neurosci. Res. pmid:15920744
Ortega-Gutiérrez S et al. Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. 2005 Glia pmid:15920730
Ahern GP et al. Extracellular cations sensitize and gate capsaicin receptor TRPV1 modulating pain signaling. 2005 J. Neurosci. pmid:15917451
Jia Y et al. TRPV1 receptor: a target for the treatment of pain, cough, airway disease and urinary incontinence. 2005 Drug News Perspect. pmid:15915217
Hillard CJ and Jarrahian A Accumulation of anandamide: evidence for cellular diversity. 2005 Neuropharmacology pmid:15910883
Venderova K et al. Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. 2005 Exp. Neurol. pmid:15899265
Vandevoorde S and Fowler CJ Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. 2005 Br. J. Pharmacol. pmid:15895107
van der Stelt M et al. A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. 2005 FASEB J. pmid:15894565
Kaplan BL et al. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide. 2005 Toxicol. Appl. Pharmacol. pmid:15893538
Guo Y et al. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. 2005 J. Biol. Chem. pmid:15890658
Ashton CH et al. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. 2005 J. Psychopharmacol. (Oxford) pmid:15888515
Osei-Hyiaman D et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. 2005 J. Clin. Invest. pmid:15864349
Glass M et al. Misidentification of prostamides as prostaglandins. 2005 J. Lipid Res. pmid:15863842
Pisani A et al. High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients. 2005 Ann. Neurol. pmid:15852389
Mishima K et al. Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. 2005 Stroke pmid:15845890
Siegmund SV et al. Anandamide induces necrosis in primary hepatic stellate cells. 2005 Hepatology pmid:15841466
Monteleone P et al. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. 2005 Neuropsychopharmacology pmid:15841111
Kwolek G et al. Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats. 2005 Br. J. Pharmacol. pmid:15834445
Randall MD The cardiovascular actions of anandamide: more targets? 2005 Br. J. Pharmacol. pmid:15834438
Chen JZ et al. Preferred conformations of endogenous cannabinoid ligand anandamide. 2005 Life Sci. pmid:15826873
Chen J et al. Finding of endocannabinoids in human eye tissues: implications for glaucoma. 2005 Biochem. Biophys. Res. Commun. pmid:15823551
O'Sullivan SE et al. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide. 2005 Br. J. Pharmacol. pmid:15821751
Pacher P et al. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15821037
Tóth A et al. Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1. 2005 Life Sci. pmid:15820503
Kvasnicka T [Endocannabinoids--the new option in the treatment of metabolic syndrome and in smoking cessation]. 2005 Cas. Lek. Cesk. pmid:15807291
Kurabayashi M et al. 2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver. 2005 Jan-Feb J Invest Surg pmid:15804949
Chen P et al. Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. 2005 Microvasc. Res. pmid:15797258
Fowler CJ and Tiger G Cyclooxygenation of the arachidonoyl side chain of 1-arachidonoylglycerol and related compounds block their ability to prevent anandamide and 2-oleoylglycerol metabolism by rat brain in vitro. 2005 Biochem. Pharmacol. pmid:15794945
De Bank PA et al. A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening. 2005 Biochem. Pharmacol. pmid:15794939
Sandberg A and Fowler CJ Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin. 2005 Chem. Phys. Lipids pmid:15784231
Minowa S et al. Capsaicin- and anandamide-induced gastric acid secretion via vanilloid receptor type 1 (TRPV1) in rat brain. 2005 Brain Res. pmid:15781048
Fezza F et al. Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity. 2005 Anal. Biochem. pmid:15766717
Zhang N et al. A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:15764707